Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate has been made of the cost to the NHS of taking on patients who were previously receiving care from Rutherford Health prior to its liquidation.

The Department did not provide an assessment of the cost, clinical impact, or NHS England’s treatment timelines associated with transitioning patients from Rutherford Health centres. This includes the Bomarsund site, prior to the organisation's liquidation. The Government is committed to improving performance for diagnosing and treating cancer. To support these objectives, the National Health Service is currently making use of two of the five former Rutherford Cancer sites, Taunton and Clatterbridge.